Sign in
4

Changes in Ownership

Odyssey Health, Inc. Filed Acc 0001683168-22-004244

Options or other derivatives

  • VP of Drug Development acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

VANLANDINGHAM JACOB PH.D · VP of Drug Development

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 $0.30 $30,000 1,100,000 D
Loading xslF345X03/ownership.xml…